Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-09

Clinical Trial Update: Pharmacokinetic Study of Topical GSK2894512 Cream [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 pharmacokinetic study of the topical GSK2894512 cream for atopic dermatitis. The sponsor is Glaxo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GSK2894512 cream (GSK2894512)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dermatitis, Atopic | Phase 1 | Status: COMPLETED